Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58.5M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+163K
-
Total reported value, excl. options
-
$9.14M
-
Value change
-
+$217K
-
Number of buys
-
19
-
Number of sells
-
-11
-
Price
-
$0.69
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q3 2025
50 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q3 2025.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 58.5M outstanding shares and own 22.69% of the company stock.
Largest 10 shareholders include ACORN CAPITAL ADVISORS, LLC (4.84M shares), VANGUARD GROUP INC (1.95M shares), TANG CAPITAL MANAGEMENT LLC (1.37M shares), ACADIAN ASSET MANAGEMENT LLC (930K shares), RENAISSANCE TECHNOLOGIES LLC (801K shares), DEUTSCHE BANK AG\ (525K shares), GEODE CAPITAL MANAGEMENT, LLC (495K shares), BlackRock, Inc. (481K shares), MILLENNIUM MANAGEMENT LLC (341K shares), and CITADEL ADVISORS LLC (274K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.